礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LLY 礼来

已收盘 09-18 16:00:00 EDT

904.97

-1.21

-0.13%

盘后906.44

+1.47+0.16%

19:59 EDT

最高915.50	最低903.46	成交量177.70万
今开906.31	昨收906.18	日振幅1.33%
总市值8,601亿	流通市值8,579亿	总股本9.50亿
成交额16.12亿	换手率0.19%	流通股本9.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":904.97,"timestamp":1726689600000,"preClose":906.18,"halted":0,"volume":1776976,"hourTrading":{"tag":"盘后","latestPrice":906.44,"preClose":904.97,"latestTime":"19:59 EDT","volume":84857,"amount":76798054.229301,"timestamp":1726703979422},"delay":0,"floatShares":948000000,"shares":950425778,"eps":8.121151,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.21,"latestTime":"09-18 16:00:00 EDT","open":906.31,"high":915.5,"low":903.46,"amount":1612456916.02976,"amplitude":0.013287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.121151,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726732800000},"adr":0,"listingDate":102488400000,"adjPreClose":906.18,"adrRate":0,"dividendRate":0.00537,"preHourTrading":{"tag":"盘前","latestPrice":908.45,"preClose":906.18,"latestTime":"09:29 EDT","volume":3171,"amount":2877528.7065,"timestamp":1726666194954},"postHourTrading":{"tag":"盘后","latestPrice":906.44,"preClose":904.97,"latestTime":"19:59 EDT","volume":84857,"amount":76798054.229301,"timestamp":1726703979422},"volumeRatio":0.787208,"impliedVol":0.3248,"impliedVolPercentile":0.5198},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2468332604","title":"医疗行业研究：康方生物重磅数据公布，三季报重点关注药品板块和个股反转","url":"https://stock-news.laohu8.com/highlight/detail?id=2468332604","media":"国金证券","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468332604?lang=zh_cn&edition=full","pubTime":"2024-09-17 18:08","pubTimestamp":1726567685,"startTime":"0","endTime":"0","summary":"行业投资逻辑整体来看，医药依然维持偏弱走势，自2024年初以来生物医药行业下跌19%，位列所有31个申万1级行业的第23位，同期沪深300指数上涨5.6个百分点。同时截至9月1日，已有19个省份及生产建设兵团将辅助生殖技术纳入医保报销范围，纳入医保后，患者支付压力降低，存量及新增需求快速释放。同时，考虑去年同期医疗服务、消费医疗、上游供应链等板块整体基数较低，建议关注这些领域个股业绩增速反弹机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409171808139f027e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409171808139f027e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LLY","LU1720050803.USD","LU0348784397.USD","IE00B543WZ88.USD","LU0417516571.SGD","NVDA","LU2488822045.USD","BK1161","LU0348783233.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","BK1574","09926","IE00BPRC5H50.USD"],"gpt_icon":1},{"id":"1122192791","title":"美联储降息赢家是谁？这10只股票在美国经济不衰退情况下历史表现最好","url":"https://stock-news.laohu8.com/highlight/detail?id=1122192791","media":"老虎资讯综合","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122192791?lang=zh_cn&edition=full","pubTime":"2024-09-17 10:26","pubTimestamp":1726539999,"startTime":"0","endTime":"0","summary":"伴随投资者为本周的美联储会议做准备，CNBC Pro 发现，在没有经济衰退环境的情况下降息时，历史上表现良好的股票。许多人现在预计美联储将实现备受期待的“软着陆”，即在不引发经济衰退的情况下抑制通胀。如果包括经济衰退的情况，这一增长下滑至略高于 11%。鉴于这一背景，CNBC Pro筛选出了在美联储降息但美国经济未陷入衰退的时期表现出色的股票。这家零售商是2024年道指表现最好的公司，涨幅高达53%。","market":"us","thumbnail":"https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美联储降息赢家是谁？这10只股票在美国经济不衰退情况下历史表现最好","news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBWI","PAYX","LLY","CHD","HRL","NKE","WMT","AMGN","TSN","UNH"],"gpt_icon":1},{"id":"1129282521","title":"礼来公司的翻身奇迹","url":"https://stock-news.laohu8.com/highlight/detail?id=1129282521","media":"财富FORTUNE","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129282521?lang=zh_cn&edition=full","pubTime":"2024-09-16 07:31","pubTimestamp":1726443077,"startTime":"0","endTime":"0","summary":"但最近一段时期，礼来公司却有了很多值得庆祝的事情。礼来公司目前在全球最有价值的公司的排行榜中名列第9位。2023年，礼来公司的销售额创下历史新高，达到341.241亿美元，比上年增长约20%。今年的早些时候，礼来公司仍然处于实验阶段的一种基因疗法还成功治愈了一名耳聋儿童。今年夏天，礼来公司还当上了美国队的奥运赞助商。然而，替尔泊肽受欢迎的程度，甚至超过了礼来公司最疯狂的预测。此时的礼来公司已经多年没有推出新药了。","market":"us","thumbnail":"https://static.tigerbbs.com/c8781df6810484711a3f13f4ff7b6283","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c8781df6810484711a3f13f4ff7b6283"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/BJKov7QGY6i4n7S1krsSug","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"礼来公司的翻身奇迹","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1651116200640","symbols":["LU0256863811.USD","LU0198837287.USD","LU0708995401.HKD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0672654240.SGD","LU0320765059.SGD","LU0820561818.USD","IE00B4R5TH58.HKD","BK4588","LU1069344957.HKD","LU0823416689.USD","LU0058720904.USD","LU0006306889.USD","BK4581","IE00BJJMRZ35.SGD","LLY","IE0002141913.USD","BK4516"],"gpt_icon":1},{"id":"2467748022","title":"礼来(LLY.US)重磅新药“替尔泊肽”新适应症在华申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2467748022","media":"智通财经网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467748022?lang=zh_cn&edition=full","pubTime":"2024-09-15 09:59","pubTimestamp":1726365580,"startTime":"0","endTime":"0","summary":"中国国家药监局药品审评中心(CDE)网站最新公示，礼来(LLY.US)重磅药物GIP/GLP-1受体双重激动剂替尔泊肽注射液新适应症上市申请获得受理，具体适应症尚未披露。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240915/20240915095209_74099.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240915/20240915095209_74099.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"礼来(LLY.US)重磅新药“替尔泊肽”新适应症在华申报上市","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00BFTCPJ56.SGD","LU0882574055.USD","LU0456855351.SGD","LU1069344957.HKD","LU0198837287.USD","BK4533","IE00BK4W5L77.USD","BK4588","IE00BK4W5M84.HKD","LU0466842654.USD","LU0354030511.USD","LU0471298777.SGD","IE0009355771.USD","LU0820561909.HKD","LU0256863902.USD","BK4007","LU1280957306.USD","LU0320765059.SGD","LU0006306889.USD","GB00BDT5M118.USD","LU1061106388.HKD","LU1267930730.SGD","LU1057294990.SGD","LU0882574139.USD","LU0061475181.USD","LU0106261372.USD","LU1551013342.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU0943347566.SGD","LU0354030438.USD","LU0385154629.USD","LU0289739699.SGD","LU0823416689.USD","BK4516","LLY","IE00BJJMRZ35.SGD","BK4534","LU0097036916.USD","LU1023059063.AUD","LU0689472784.USD","LU0708995401.HKD","LU1064131342.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE0004445239.USD","LU0820561818.USD","IE0002141913.USD","LU0109391861.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2467606398","title":"礼来计划投资10亿美元扩建爱尔兰生产基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2467606398","media":"格隆汇","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467606398?lang=zh_cn&edition=full","pubTime":"2024-09-14 14:01","pubTimestamp":1726293700,"startTime":"0","endTime":"0","summary":"格隆汇9月14日｜美国制药巨头礼来公司宣布计划投资10亿美元扩建其位于爱尔兰利默里克的生产基地，使该公司在利默里克地区的投资总额达到20亿美元。计划中的扩建将增加生物活性成分的产量，包括最近获批的用于治疗早期症状性阿尔茨海默病的药物。礼来预计将于2026年开始生产这些药物成分。此举将为利默里克创造150个就业岗位，使该生产基地的员工总数达到450人，生产基地提供的职位包括工程师、科学家、质量保证专业人员和操作人员。该投资需获得规划批准，目前礼来公司正准备向利默里克市和郡议会提交规划申请。礼来公司还宣布斥资8亿美元扩建其位于科克郡金塞尔的工厂，该工厂去年开始生产治疗糖尿病和肥胖症的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914140210956498b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914140210956498b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640476718.USD","LU0238689110.USD","LU0256863811.USD","LU0820561909.HKD","IE00BJLML261.HKD","LU0198837287.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0823416689.USD","GB00BDT5M118.USD","LU0320765059.SGD","BK4585","LU0354030438.USD","BK4007","BK4581","LU0672654240.SGD","LU0882574055.USD","LU1069344957.HKD","IE0004445239.USD","LU0417517546.SGD","LU0106261372.USD","LU0079474960.USD","LU0466842654.USD","LU1035775433.USD","LU0385154629.USD","LLY","LU0471298694.HKD","LU0882574139.USD","LU0689472784.USD","BK4516","LU0256863902.USD","LU0058720904.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU1551013342.USD","LU0471298777.SGD","LU0456855351.SGD","IE00B4R5TH58.HKD","LU1267930730.SGD","IE0009355771.USD","LU0122379950.USD","LU0114720955.EUR","LU0097036916.USD","LU1064131342.USD","LU1061106388.HKD","LU0820561818.USD","LU0354030511.USD","IE00BFTCPJ56.SGD","BK4588","LU0096364046.USD"],"gpt_icon":0},{"id":"2467700863","title":"礼来下跌1.21%，报923.711美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467700863","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467700863?lang=zh_cn&edition=full","pubTime":"2024-09-14 02:38","pubTimestamp":1726252688,"startTime":"0","endTime":"0","summary":"9月14日，礼来(LLY)盘中下跌1.21%，截至02:38，报923.711美元/股，成交10.91亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月9日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。11月7日，礼来将披露2024财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/14023843272570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0820561909.HKD","LU1035775433.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU1061106388.HKD","IE00BK4W5L77.USD","IE00B1BXHZ80.USD","LU0058720904.USD","LU0061475181.USD","LU0109391861.USD","BK4007","LU0466842654.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0943347566.SGD","BK4533","IE0009355771.USD","LLY","LU0354030511.USD","LU0689472784.USD","LU0079474960.USD","IE0004445239.USD","LU0471298694.HKD","LU0006306889.USD","BK4534","LU0094547139.USD","IE00BJJMRZ35.SGD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU0672654240.SGD","LU0122379950.USD","LU0385154629.USD","BK4585","LU0882574139.USD","LU0289739699.SGD","BK4516","LU0096364046.USD","LU0708995401.HKD","LU0354030438.USD","LU0820561818.USD","BK4588","LU1069344957.HKD","LU0882574055.USD","IE0002141913.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1280957306.USD","LU0097036916.USD","LU1551013342.USD"],"gpt_icon":1},{"id":"2467277583","title":"看好“减肥神药”前景 花旗重新覆盖礼来(LLY.US) 予以“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2467277583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467277583?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:35","pubTimestamp":1726234500,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在评级暂停一段时间后，花旗恢复了对礼来评级。该行给予其“买入”评级，目标价1060美元，理由是看好该公司的GLP-1产品线销售额前景，其中包括其畅销的有着“减肥神药”称号畅销减肥药物Zepbound，该药物的核心成分为替尔泊肽。分析师Peter Verdult的看涨观点基于对替尔泊肽的预测上调，替尔泊肽分别以Mounjaro和Zepbound命名用于治疗糖尿病和肥胖症。该分析师根据该药物最新的销售报告以及处方趋势和指导得出了结论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY"],"gpt_icon":1},{"id":"2467725112","title":"礼来四赴服贸会 赋能中国医药创新高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2467725112","media":"21世纪经济报道","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467725112?lang=zh_cn&edition=full","pubTime":"2024-09-13 19:19","pubTimestamp":1726226393,"startTime":"0","endTime":"0","summary":"2024年中国国际服务贸易交易会（以下称“服贸会”）于9月12日在北京正式开幕，这是礼来第四年参加服贸会，围绕本届大会“全球服务，互惠共享”主题，礼来重点展示了在糖尿病、肥胖及阿尔茨海默病领域的最新创新成果，并与本土临床研究机构达成合作，共同推动全球同步研发，加速全球创新药惠及中国患者，并携手助力中国创新走向世界。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202409133183186972.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409133183186972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0471298694.HKD","LU1069344957.HKD","LU0122379950.USD","LU0354030438.USD","LU0006306889.USD","LU1057294990.SGD","GB00BDT5M118.USD","IE0002141913.USD","BK4581","LU0689472784.USD","LU0882574139.USD","LU0079474960.USD","LU1551013342.USD","IE00B4R5TH58.HKD","LU0385154629.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU0198837287.USD","LU0823416689.USD","LU0109391861.USD","LU1064131342.USD","LU0061475181.USD","LU0708995401.HKD","LU0094547139.USD","IE00BJJMRZ35.SGD","BK4585","LU0058720904.USD","IE0004445239.USD","BK4516","LU1280957306.USD","LLY","IE00BFTCPJ56.SGD","LU0466842654.USD","LU0256863811.USD","LU0354030511.USD","BK4588","IE00B2B36J28.USD","LU0114720955.EUR","BK4007","LU1061106388.HKD","LU1035775433.USD","IE0009355771.USD","LU0096364046.USD","LU0097036916.USD","LU0640476718.USD","LU0820561909.HKD","IE00BJLML261.HKD","LU0943347566.SGD","IE00B1BXHZ80.USD","LU0820561818.USD"],"gpt_icon":1},{"id":"2467714846","title":"美国研究综述-星座能源公司、礼来公司、塔伦能源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2467714846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467714846?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:51","pubTimestamp":1726213914,"startTime":"0","endTime":"0","summary":"    路透9月13日 - 周五，华尔街证券分析师修改了对几家美国上市公司的评级和目标价，其中包括星座能源公司、礼来公司和泰伦能源公司。* Fulcrum Therapeutics Inc   ：加拿大皇家银行将目标价从15美元下调至4美元 * Fulcrum Therapeutics Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","HAL","LU1267930813.SGD","IBEX","ORKA","FERG","JNJ","LU0965509101.SGD","SHLS","LU2298322129.HKD","MODV","FULC","ZBH","LH","VRDN","USB","BK4581","LU1244550577.SGD","IE00BLSP4239.USD","WDC","PLAY","RH","IE00BLSP4452.SGD","VST","BK4592","NRG","LU0417517546.SGD","TLN","TTD","CEG","DOW","BK4105","BK4216","LLY","LU0234572021.USD","IE00BMG7P587.USD","KR","KIDS","IE00BD4GTT62.SGD","ALK","PEG","LU0130102774.USD","BK4212","EW","AVTR","CPB","GEV"],"gpt_icon":1},{"id":"2467766510","title":"18亿美元！礼来建厂、扩大GLP-1产量","url":"https://stock-news.laohu8.com/highlight/detail?id=2467766510","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467766510?lang=zh_cn&edition=full","pubTime":"2024-09-13 09:37","pubTimestamp":1726191435,"startTime":"0","endTime":"0","summary":"9月12日，礼来表示，该公司已经完成了耗资8亿美元的Kinsale工厂扩建工程，以增加其肥胖和糖尿病药物Mounjaro和Zepbound的产量。施工需获得规划批准，礼来计划很快提交申请。2022年1月，礼来投资4.46亿美元扩大原料药和单克隆抗体的生产。礼来和竞争对手诺和诺德一直在竞相促进各自GLP-1的生产。2022年，辉瑞表示将向都柏林工厂投入近10亿美元。阿斯利康还在 2021 年预算了 3.6 亿美元来建造其第一个爱尔兰工厂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913095702956195aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913095702956195aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","LU0106261372.USD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0672654240.SGD","LU0096364046.USD","LU0114720955.EUR","LU0820561909.HKD","LU0708995401.HKD","LU1057294990.SGD","IE0002141913.USD","IE0009355771.USD","LU1035775433.USD","LU0943347566.SGD","LU0238689110.USD","LU0417517546.SGD","LU0058720904.USD","LU0061475181.USD","LU0354030438.USD","LU0094547139.USD","LU0354030511.USD","IE00B1BXHZ80.USD","BK4516","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0097036916.USD","LU0109391861.USD","LU1551013342.USD","LU1280957306.USD","IE00BJLML261.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00BK4W5M84.HKD","BK4581","BK4588","LU0882574055.USD","BK4144","BK4585","LLY","LU0385154629.USD","LU0006306889.USD","IE0004445239.USD","BK4007","LU0471298694.HKD","LU0320765059.SGD","GLP","BK4590","LU0122379950.USD","LU1061106388.HKD","LU0079474960.USD"],"gpt_icon":1},{"id":"2466749206","title":"礼来上涨1.35%，报933.33美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466749206","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466749206?lang=zh_cn&edition=full","pubTime":"2024-09-12 22:13","pubTimestamp":1726150439,"startTime":"0","endTime":"0","summary":"9月12日，礼来(LLY)盘中上涨1.35%，截至22:13，报933.33美元/股，成交5.0亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月9日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/12221343226410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0708995401.HKD","LU0114720955.EUR","IE0004445239.USD","BK4588","LU0354030438.USD","IE00BJLML261.HKD","BK4516","BK4533","LU0006306889.USD","LU0289739699.SGD","BK4581","LU0820561818.USD","LU0882574055.USD","LU0943347566.SGD","LU0096364046.USD","LU0058720904.USD","LU1035775433.USD","LU0094547139.USD","BK4585","LU0109391861.USD","GB00BDT5M118.USD","LU0689472784.USD","LU0385154629.USD","IE0009355771.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0466842654.USD","LU0823416689.USD","LU0256863811.USD","LU0097036916.USD","LU1023059063.AUD","LU0882574139.USD","LU0820561909.HKD","IE00BK4W5L77.USD","LU0354030511.USD","LLY","IE00BJJMRZ35.SGD","LU0061475181.USD","IE00BK4W5M84.HKD","LU0122379950.USD","LU0079474960.USD","LU1551013342.USD","BK4007","LU1061106388.HKD","IE0002141913.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU0471298694.HKD","LU1280957306.USD"],"gpt_icon":1},{"id":"2466885203","title":"斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2466885203","media":"华尔街见闻","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466885203?lang=zh_cn&edition=full","pubTime":"2024-09-12 21:39","pubTimestamp":1726148365,"startTime":"0","endTime":"0","summary":"礼来的减肥药被认为是历史上最畅销的药物之一。本次，礼来计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3727852","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3727852","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU0820561909.HKD","LU1035775433.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU1061106388.HKD","IE00BK4W5L77.USD","IE00B1BXHZ80.USD","LU0058720904.USD","LU0061475181.USD","LU0109391861.USD","BK4007","LU0466842654.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0943347566.SGD","BK4533","IE0009355771.USD","LLY","LU0354030511.USD","LU0689472784.USD","LU0079474960.USD","IE0004445239.USD","LU0471298694.HKD","LU0006306889.USD","BK4534","LU0094547139.USD","IE00BJJMRZ35.SGD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU0122379950.USD","LU0385154629.USD","BK4585","LU0882574139.USD","LU0289739699.SGD","BK4516","LU0096364046.USD","LU0708995401.HKD","LU0354030438.USD","LU0820561818.USD","BK4588","LU1069344957.HKD","LU0882574055.USD","IE0002141913.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0823416689.USD","LU1023059063.AUD","LU1280957306.USD","LU0097036916.USD","LU1551013342.USD"],"gpt_icon":1},{"id":"2466922605","title":"礼来投资 18 亿美元在爱尔兰建厂，以扩大阿尔茨海默氏症和肥胖症药物的生产规模","url":"https://stock-news.laohu8.com/highlight/detail?id=2466922605","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466922605?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:30","pubTimestamp":1726133409,"startTime":"0","endTime":"0","summary":"    路透9月12日 -    礼来   制药公司周四表示，将投资18亿美元在爱尔兰的两个生产基地，以提高其广受欢迎的肥胖症药物和一种新批准的阿尔茨海默氏症治疗药物的产量。其余投资将用于扩建这家制药商在爱尔兰 利默里克的工厂， 该工厂将重点生产某些药物 的活性生物成分，包括 治疗阿尔茨海默氏症的药物 。礼来治疗阿尔茨海默氏症的药物已于今年 7 月获得美国批准， 目前正在  接受欧洲和英国卫生监管机构的审查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1267930730.SGD","LU0058720904.USD","LU0109391861.USD","LU0882574139.USD","LU1064131342.USD","LU0466842654.USD","LU0114720955.EUR","LU1035775433.USD","LU0689472784.USD","LU0820561818.USD","LU0289739699.SGD","LU1023059063.AUD","IE00B2B36J28.USD","LU1280957306.USD","LU0097036916.USD","LU0006306889.USD","LU0640476718.USD","LU0061475181.USD","IE00B1BXHZ80.USD","LU0094547139.USD","LU0106261372.USD","LU0708995401.HKD","LU0198837287.USD","LLY","IE00BK4W5M84.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00BK4W5L77.USD","LU0096364046.USD","LU0417517546.SGD","LU0823416689.USD","LU0471298777.SGD","CTLT","BK4585","LU0672654240.SGD","LU0238689110.USD","LU0320765059.SGD","BK4588","BK4533","LU0122379950.USD","LU0820561909.HKD","LU0256863902.USD","BK4581","BK4534","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0385154629.USD","LU1069344957.HKD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2466238470","title":"晨星公司料诺和诺德(NVO和礼来(LLY)仍主导GLP-1类减肥药物市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466238470","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466238470?lang=zh_cn&edition=full","pubTime":"2024-09-11 17:08","pubTimestamp":1726045696,"startTime":"0","endTime":"0","summary":"晨星公司补充称，这些新药可能会从诺和诺德和礼来手中夺走部分市场份额，但这两家减肥药巨头仍将保留近70%的市场份额。不过，该公司也认为，诺和诺德与礼来的股票“估值过高”。此外，更多的竞争也会给GLP-1类减肥药物价格带来额外的压力。晨星公司预计，到2027年，随着竞争对手努力进入医疗保险覆盖范围，新进入者将导致GLP-1类减肥药物价格年跌幅加速至10%-15%。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279785","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0094547139.USD","IE00BK4W5M84.HKD","LU0122379950.USD","PFE","IE00BLSP4452.SGD","LU0321505439.SGD","GPCR","LU1280957306.USD","IE0002270589.USD","LU0320765992.SGD","LU0708995401.HKD","LLY","SGXZ57979304.SGD","LU0225771236.USD","IE00BBT3K403.USD","BK4533","03165","LU0058720904.USD","IE00BK4W5L77.USD","LU0289739699.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","IE00BZ1G4Q59.USD","LU0234572021.USD","LU0006306889.USD","BK4532","NVO","LU1093756168.USD","LU1035775433.USD","LU1571399168.USD","AMGN","SG9999001440.SGD","LU1983299246.USD","SG9999013999.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","AZN","BK4007","LU0321505868.SGD","BK4534","GLP","IE00BLSP4239.USD","LU1023059063.AUD","SG9999001176.USD","LU0109391861.USD","RHHBY","LU0061475181.USD","LU2236285917.USD","LU0471298694.HKD"],"gpt_icon":1},{"id":"2466203004","title":"晨星公司：2029年或有多达16种新的GLP-1类减肥药物上市 诺和诺德和礼来仍主导市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466203004","media":"格隆汇","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466203004?lang=zh_cn&edition=full","pubTime":"2024-09-11 14:26","pubTimestamp":1726035988,"startTime":"0","endTime":"0","summary":"格隆汇9月11日｜根据晨星公司和Pitchbook的一份新报告，到2029年，可能会有多达16种新的GLP-1类减肥药物上市，最终将占据到2031年潜在的2000亿美元市场的近三分之一。晨星公司预计，到2031年，该市场仍将由诺和诺德和礼来主导。这些新药可能会从诺和诺德和礼来手中夺走部分市场份额，但这两家减肥药巨头仍将保留近70%的市场份额。此外，晨星公司预计，到2027年，随着竞争对手努力进入医疗保险覆盖范围，新进入者将导致GLP-1类减肥药物价格年跌幅加速至10%-15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409111426409ef40643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409111426409ef40643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0114720955.EUR","LU1267930730.SGD","LU0256863902.USD","BK4516","BK4533","BK4534","LU0154236417.USD","LU0456855351.SGD","BK4532","IE00B2B36J28.USD","GLP","LU0289739699.SGD","LU0820561818.USD","LU0943347566.SGD","LU0198837287.USD","LU2065731478.USD","LU0096364046.USD","LU0417517546.SGD","LU0471298777.SGD","LU0094547139.USD","LU1064131342.USD","BK4585","MORN","LU0385154629.USD","IE0009355771.USD","BK4590","LU0320765059.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU0640476718.USD","LU1069344957.HKD","LU0466842654.USD","LU0823416689.USD","LU0097036916.USD","LU0672654240.SGD","LU0882574139.USD","NVO","LU0820561909.HKD","IE00B4R5TH58.HKD","IE00BK4W5L77.USD","LLY","IE00BKVL7J92.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU0238689110.USD","BK4112","BK4007","LU1057294990.SGD","LU1023059063.AUD","PFE"],"gpt_icon":1},{"id":"2466441403","title":"16款新GLP-1类减肥药或于2029年上市 但诺和诺德(NVO.US)、礼来(LLY.US)仍将主导市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466441403","media":"智通财经网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466441403?lang=zh_cn&edition=full","pubTime":"2024-09-11 10:44","pubTimestamp":1726022699,"startTime":"0","endTime":"0","summary":"根据晨星公司和Pitchbook的一份新报告，到2029年，可能会有多达16种新的GLP-1类减肥药物上市，最终将占据到2031年潜在的2000亿美元市场的近三分之一。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240911/20240911095514_50271.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240911/20240911095514_50271.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00BFTCPJ56.SGD","LU0456855351.SGD","BK4532","BK4144","LU1069344957.HKD","LU0198837287.USD","BK4533","IE00BK4W5L77.USD","BK4588","LU0094547139.USD","IE00BK4W5M84.HKD","LU0466842654.USD","LU0471298777.SGD","LU0820561909.HKD","IE0009355771.USD","NVO","LU0256863902.USD","BK4007","BK4581","LU0320765059.SGD","IE00BZ1G4Q59.USD","LU0006306889.USD","LU1267930730.SGD","LU1057294990.SGD","LU0882574139.USD","LU0154236417.USD","LU0061475181.USD","IE00BKVL7J92.USD","LU0106261372.USD","LU0238689110.USD","PFE","IE00B2B36J28.USD","LU0417517546.SGD","LU0385154629.USD","LU0289739699.SGD","LU0823416689.USD","LLY","BK4534","LU0097036916.USD","LU0640476718.USD","LU1023059063.AUD","LU0689472784.USD","LU1064131342.USD","LU0672654240.SGD","BK4590","IE00B4R5TH58.HKD","LU0820561818.USD","LU0109391861.USD","GLP","LU1093756168.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2466449391","title":"健康巡讲：礼来公司生产的每周一次的胰岛素似乎与每天注射的胰岛素一样有效","url":"https://stock-news.laohu8.com/highlight/detail?id=2466449391","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466449391?lang=zh_cn&edition=full","pubTime":"2024-09-11 03:43","pubTimestamp":1725997439,"startTime":"0","endTime":"0","summary":"礼来每周一次的胰岛素与每天注射的胰岛素一样有效研究人员周二在马德里举行的欧洲糖尿病研究协会会议上说，礼来公司的  实验性胰岛素每周只需注射一次，在维持1型或2型糖尿病患者的血糖水平方面与每天注射胰岛素一样有效。在两项后期试验中，研究人员比较了每周注射胰岛素 efsitora alfa 或每天注射胰岛素 degludec 一年来的血糖管理效果。今年7月，礼来的竞争对手诺和诺德公司的每周一次的基础胰岛素icodec注射剂未能获得美国批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Breakthrough in Diabetes Treatment: Eli Lilly's Once-Weekly Insulin Shows Promise","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0106261372.USD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0672654240.SGD","LU0820561909.HKD","LU0114720955.EUR","LU1057294990.SGD","LU1267930730.SGD","IE0002141913.USD","LU0198837287.USD","IE0009355771.USD","LU0943347566.SGD","LU0238689110.USD","LU0417517546.SGD","BK4534","LU0354030438.USD","LU0094547139.USD","LU0354030511.USD","IE00B1BXHZ80.USD","LU1069344957.HKD","BK4516","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU0689472784.USD","LU0109391861.USD","LU1551013342.USD","LU1280957306.USD","LU1023059063.AUD","IE00BK4W5M84.HKD","BK4581","BK4588","LU0882574055.USD","LU0640476718.USD","BK4585","LLY","LU0466842654.USD","LU0385154629.USD","IE00B4R5TH58.HKD","IE0004445239.USD","LU0823416689.USD","BK4007","LU0320765059.SGD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1061106388.HKD","LU0471298777.SGD","LU0079474960.USD"],"gpt_icon":1},{"id":"2466467286","title":"报告估计，到 2029 年，减肥市场将出现 16 种新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2466467286","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466467286?lang=zh_cn&edition=full","pubTime":"2024-09-11 02:41","pubTimestamp":1725993676,"startTime":"0","endTime":"0","summary":"在周一发表的一份联合报告中，分析师们估计，到2031年，肥胖症治疗市场的规模将扩大到2000亿美元。到 2029 年，这 16 种药物将陆续上市，其中大约 700 亿美元的 GLP-1 市场将来自这些新的挑战者。背景 报告称，潜在的新疗法包括勃林格殷格翰公司和西兰制药公司  的产品，以及罗氏  、安进  和辉瑞  的竞争产品，前提是这些药物通过临床试验。报告预计，到 2031 年，41% 的糖尿病患者和近四分之一的非糖尿病肥胖症患者将服用 GLP-1 药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1035775433.USD","IE00B1BXHZ80.USD","LU1571399168.USD","LU1061106388.HKD","LU0882574055.USD","BK4533","IE00BK4W5L77.USD","LU0058720904.USD","LU0354030511.USD","SG9999001440.SGD","GB00BDT5M118.USD","IE00BJT1NW94.SGD","LU0943347566.SGD","BK4534","LU0109391861.USD","LU0471298694.HKD","LU1023059063.AUD","LU2242646821.SGD","LU2242652126.USD","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU1280957306.USD","PFE","LU1057294990.SGD","LU0868494617.USD","LU0708995401.HKD","LU0320765992.SGD","LU0114720955.EUR","LU0122379950.USD","LU0289739699.SGD","LU0354030438.USD","IE00BK4W5M84.HKD","LU1551013342.USD","LU0672654240.SGD","IE0002141913.USD","LLY","AMGN","BK4566","LU0006306889.USD","BK4007","IE0004445239.USD","LU0094547139.USD","LU0256863811.USD","LU0238689110.USD","LU1983299246.USD","LU2112291526.USD","LU0079474960.USD","IE00BJLML261.HKD","BK4516"],"gpt_icon":1},{"id":"2466746323","title":"礼来下跌1.24%，报897.05美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466746323","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466746323?lang=zh_cn&edition=full","pubTime":"2024-09-11 00:03","pubTimestamp":1725984195,"startTime":"0","endTime":"0","summary":"9月11日，礼来(LLY)盘中下跌1.24%，截至00:03，报897.05美元/股，成交6.56亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月9日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/11000343165518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4585","LU0417517546.SGD","LU0114720955.EUR","BK4581","BK4534","LU0198837287.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0820561818.USD","LU0456855351.SGD","BK4533","LU0823416689.USD","GB00BDT5M118.USD","LU0097036916.USD","LU1267930730.SGD","LU1551013342.USD","LU0320765059.SGD","IE0002141913.USD","LU0672654240.SGD","LU0096364046.USD","LU0256863902.USD","LU1057294990.SGD","LU0466842654.USD","LU1069344957.HKD","IE00BK4W5M84.HKD","LU0079474960.USD","LU0640476718.USD","LU0094547139.USD","LU0943347566.SGD","BK4588","LU0882574139.USD","LU0109391861.USD","LU0006306889.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU1064131342.USD","LU0106261372.USD","LU0882574055.USD","LU0689472784.USD","LU1023059063.AUD","IE00BK4W5L77.USD","LU0385154629.USD","LU0238689110.USD","LU0354030438.USD","LLY","LU0061475181.USD","IE00B2B36J28.USD","LU0471298777.SGD","LU0820561909.HKD"],"gpt_icon":1},{"id":"1155491984","title":"美股难逃9月魔咒？这11只稳健股或是最佳避风港","url":"https://stock-news.laohu8.com/highlight/detail?id=1155491984","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155491984?lang=zh_cn&edition=full","pubTime":"2024-09-10 14:32","pubTimestamp":1725949951,"startTime":"0","endTime":"0","summary":"对于那些希望在历史上波动较大的9月中保持稳健的投资者来说，一些股票可能会成为避风港。9月股市开局不佳，上周标普500指数创下自2023年3月以来最差表现。一些投资者预计最终结果不会在选举之夜揭晓，这可能会进一步拖延选举进程，并伴随带来不确定性。此外，该股的贝塔系数约为0.44，表明其波动性较低。T.J. Maxx和Marshalls的母公司2024年股价上涨约25%。接受 LSEG 调查的分析师预测 TJX 股票未来有 12% 以上的上涨空间。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/c422a86e247dd4fe60b1a3ecc0f797b2","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/c422a86e247dd4fe60b1a3ecc0f797b2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美股难逃9月魔咒？这11只稳健股或是最佳避风港","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TJX","KR","LLY","NEM","COR","LDOS","WM","CI","ELV","OMC","CTVA"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0173},{"period":"3month","weight":0.0165},{"period":"6month","weight":0.1765},{"period":"1year","weight":0.5862},{"period":"ytd","weight":0.5546}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立，其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现，开发，制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来，为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011498},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002909},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015389},{"month":4,"riseRate":0.555556,"avgChangeRate":0.018718},{"month":5,"riseRate":0.422222,"avgChangeRate":0.014916},{"month":6,"riseRate":0.6,"avgChangeRate":0.02296},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.000346},{"month":8,"riseRate":0.422222,"avgChangeRate":0.004313},{"month":9,"riseRate":0.444444,"avgChangeRate":0.001887},{"month":10,"riseRate":0.590909,"avgChangeRate":0.014439},{"month":11,"riseRate":0.75,"avgChangeRate":0.027866},{"month":12,"riseRate":0.590909,"avgChangeRate":0.031834}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}